https://www.selleckchem.com/pr....oducts/c-176-sting-i
The degradation rate of the PLCL/F-Fg1 scaffold and the rate of new tissue growth reached a balance and the biomechanical strength returned to baseline within 2 weeks of implantation. The immunohistological data demonstrated the presence of regenerated skeletal muscle tissue for PLCL/F-Fg1 scaffolds, whereas the PPM exhibited dense fibrous encapsulation along the perimeter of the mesh. CONCLUSIONS The data provides the foundation for future clinical applications of PLCL/F-Fg1 composite scaffolds for reconstructive surgery
Like
Comment
Share
